<--- Back to Details
First PageDocument Content
Syndromes / Eculizumab / Hemolytic-uremic syndrome / Thrombocytopenia / Nephrology / Renal function / Meningococcal disease / Medicine / Health / Immunosuppressants
Date: 2015-03-19 14:38:28
Syndromes
Eculizumab
Hemolytic-uremic syndrome
Thrombocytopenia
Nephrology
Renal function
Meningococcal disease
Medicine
Health
Immunosuppressants

1 INTERIM FUNDING CRITERIA IN ONTARIO FOR SOLIRIS AHUS –CASE BY CASE BASIS Initiation Criteria A patient must meet all three of the following to obtain funding for initial treatment of eculizumab for aHUS: 1. Confirmed

Add to Reading List

Source URL: www.ahuscanada.org

Download Document from Source Website

File Size: 295,81 KB

Share Document on Facebook

Similar Documents